Loading…
Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness
1 Physiology Program, Department of Environmental Health, Harvard School of Public Health, 2 Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, and 3 Perlmutter Laboratory, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115; an...
Saved in:
Published in: | Journal of applied physiology (1985) 2004-07, Vol.97 (1), p.249-259 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1 Physiology Program, Department of Environmental Health, Harvard School of Public Health, 2 Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, and 3 Perlmutter Laboratory, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115; and 4 Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520
Submitted 23 December 2003
; accepted in final form 11 March 2004
Individuals with asthma have increased levels of nitric oxide in their exhaled air. To explore its role, we have developed a regulatable transgenic mouse capable of overexpressing inducible nitric oxide synthase in a lung-specific fashion. The CC10-rtTA-NOS-2 mouse contains two transgenes, a reverse tetracycline transactivator under the control of the Clara cell protein promoter and the mouse nitric oxide synthase-2 (NOS-2) coding region under control of a tetracycline operator. Addition of doxycycline to the drinking water of CC10-rtTA-NOS-2 mice causes an increase in nitric oxide synthase-2 that is largely confined to the airway epithelium. The fraction of expired nitric oxide increases over the first 24 h from 10 parts per billion to a plateau of 20 parts per billion. There were no obvious differences between CC10-rtTA-NOS-2 mice, with or without doxycycline, and wild-type mice in lung histology, bronchoalveolar protein, total cell count, or count differentials. However, airway resistance was lower in CC10-rtTA-NOS-2 mice with doxycycline than in CC10-rtTA-NOS-2 mice without doxycycline or wild-type mice with doxycycline. Moreover, doxycycline-treated CC10-rtTA-NOS-2 mice were hyporesponsive to methacholine compared with other groups. These data suggest that increased nitric oxide in the airways has no proinflammatory effects per se and may have beneficial effects on pulmonary function.
asthma; inducible transgene; mouse; epithelial cell; methacholine
Address for reprint requests and other correspondence: E. S. Silverman, Physiology Program, Dept. of Environmental Health, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115-6021 (E-mail: esilverm{at}hsph.harvard.edu ). |
---|---|
ISSN: | 8750-7587 1522-1601 |
DOI: | 10.1152/japplphysiol.01389.2003 |